Volume 3, Problème 1 (2013)
Méthodologie du parcours clinique
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Prospective d’itinéraire clinique
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Examen : Résultats de l'essai clinique
Targeted therapy for hepatocellular carcinoma: current status and future direction
Stephen L Chan, Tony Mok
Méthodologie du parcours clinique
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Examen : Résultats de l'essai clinique
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Mise à jour de la recherche
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Méthodologie
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
